---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-107776"
form_type: "8-K"
ticker: "APVO"
cik: "0001671584"
company_name: "Aptevo Therapeutics Inc."
filed_at: "2024-09-18T23:59:59+00:00"
generated_at: "2026-05-31T03:59:00.878971+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Aptevo raises $3.0M via registered direct offering of stock and warrants at $0.33/share

## Summary
- Issued 9,090,910 shares or pre-funded warrants plus warrants for up to 18,181,820 shares at $0.33 per unit.
- Gross proceeds ~$3.0M; net proceeds ~$2.5M after fees; proceeds for clinical development and working capital.
- Existing warrants covering 11,822,774 shares amended to reduce exercise price from $0.515 to $0.33 per share.
- Warrants are exercisable upon stockholder approval and expire five years thereafter; closing occurred September 18, 2024.
- Roth Capital Partners acted as exclusive placement agent; 7.0% cash fee on gross proceeds.

## SEC filing metadata
- accession: 0000950170-24-107776
- form_type: 8-K
- ticker: APVO
- cik: 0001671584
- company_name: Aptevo Therapeutics Inc.
- filed_at: 2024-09-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671584/000095017024107776/0000950170-24-107776-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671584/000095017024107776/apvo-20240916.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-107776
- JSON: https://secwatch.observer/filing/0000950170-24-107776.json
- Plain text: https://secwatch.observer/filing/0000950170-24-107776.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.